Manufacturer record

C.B. Healthcare: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

6 batches manufactured by C.B. Healthcare (Himachal Pradesh) were declared Not of Standard Quality between November 2022 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

6 records linked to C.B. Healthcare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
6Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Nov 2022 to Feb 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

6
NSQ batches since 2022
5
Products affected
Dissolution
Most common failure
Feb 2026
Latest alert

Flagged batches per year

2022 · 22024 · 12025 · 12026 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Pantoprazole Gastro-resistant Tablets I.P CBT25-1043DMfg 2025-07 · Exp 2027-06 Test for DissolutionDissolution RDTL, Bellary, KarnatakaState lab Feb 2026
Ambroxol Hcl, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup CBL-0284/25Mfg 2025-03 · Exp 2027-02 ContentOther DTL, Chennai-06State lab Feb 2026
Tramadol Hydrochloride Capsules I.P. 50 mg CBC-0012/25Mfg 2025-01 · Exp 2026-12 Assay of Tramadol Hydrochloride.Assay CDL, KolkataCDSCO lab Aug 2025
Brokuf-DM CBL- 0024/24Mfg 2024-02 · Exp 2026-01 Sample does not conform to Label claim with respect to the content of phenylephrine Hydrochloride.Labelling DTL ChennaiState lab Dec 2024
Zenmax Tablets (Albendazole Tablets I.P.) CBT-122A/20Mfg 2021-01 · Exp 2022-12 DissolutionDissolution RDTL GuwahatiState lab Nov 2022
Zenmax Tablets (Albendazole Tablets I.P.) CBT-714/21Mfg 2021-11 · Exp 2023-10 DissolutionDissolution RDTL GuwahatiState lab Nov 2022

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.